Promoter holding
64.27%
RA
Rajasthan Antibiotics Ltd - Due diligence report
A 360° intelligence report on Rajasthan Antibiotics Ltd: trust score, financial health, credit view, compliance, directors, growth and distr…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Rajasthan Antibiotics Ltd — 360° Intelligence Report
Generated from MCA filings & public records64/100
Trust Score
Moderate
Rajasthan Antibiotics Ltd is assessed as Moderate with a Trust Score of 64/100. Rajasthan Antibiotics Ltd is an active public limited indian non-government company incorporated in 1986, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and low financial risk profile.
Report generated on 10 Aug 2026 from the latest processed filings. Rajasthan Antibiotics Ltd snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreModerate
64/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
32/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
85/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
80/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreModerate
55/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
80/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
65/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 80/100 Low Risk
- Moderate gearing (D/E 38%).
- Working-capital cover adequate.
- Profitable - internal accruals available.
Charges position: 10 open (117.84 cr) · 41 satisfied (729.68 cr).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| State Bank Of India | 11 | 48.0 cr |
| Others | 12 | 48.0 cr |
| Allahabad Bank | 4 | 48.0 cr |
| Indian Bank | 4 | 48.0 cr |
| Yes Bank Limited | 1 | 48.0 cr |
| State Bank Of Hyderabad | 1 | 48.0 cr |
Compliance Score: 32/100 Caution Indicated
- Company status is Active as per MCA.
- Annual filings current (balance sheet Mar 2025).
- Flagged by authority: CBEC.
- Litigation present in 3 court forum(s).
- 2 auditor resignation(s) filed - latest: Vineet Garg & Associates on 2021-09-14.
- Delayed payments to MSME suppliers disclosed (541 disclosure(s)).
- 2 active GST registration(s).
Legal cases on record (3)
05
Director Intelligence
Stability score: 55/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| AASHISH PRUTHII | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| BINDU ACHARYA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| VIJAYSINH VANVIRSINH CHAUHAN | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| ARVIND KHARABANDA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| RAKESH KUMAR GIRDHAR | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| RAJESH KUMAR JHA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SANJAY MITTAL | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 7 directors on the board.
- RAJESH KUMAR JHA has DIN status "Deactivated due to non-filing of DIR-3 KYC".
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
Director & KMP remuneration (FY 2024)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2024 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
1
Group entities
1
Capital events
3 allotment(s) · 3 transfer(s)
Promoters hold a majority stake - exact percentages are part of the full report.
| Group entity | Relationship | % held |
|---|---|---|
| Ral Nutralife Private Limited | Subsidiary Company | 74.00% |
Key managerial personnel: AASHISH PRUTHII (Managing Director) · RAKESH KUMAR GIRDHAR (Whole-time director) · SANJAY MITTAL (CFO)
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 80 · Distress 65
Growth signals & trust indicators
Revenue acceleration: +1.42 over 4 year(s).
Asset base grew 2.1x - capacity expansion.
EPFO headcount growing - hiring signal.
Operating for 40+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
Outside liabilities up 24% in a year.
Compliance score is weak (32/100).
10 open charge(s) registered - assets are encumbered.
2 auditor resignation(s) on record - review the stated reasons.
MSME payment delays disclosed - latest outstanding 7.20 cr.
3 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence52/100
Review suggested
Suitability as a supplier / customer counterparty.
- Check the compliance flags before onboarding.
- 2 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment70/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 10 open charge(s) of 117.84 cr already registered.
- Compliance gaps should be priced into terms.
Investor view78/100
Positive growth indicators
Growth quality and scalability through an investor lens.
- 3 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management churn warrants questions.
09
MCA Filings & Events Timeline
Latest 15 events14 Aug 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
16 Dec 2024
Charge created
Yes Bank Limited - 19.50 cr
02 Dec 2024
Charge created
Indian Bank - 7.50 cr
19 Mar 2024
Charge created
Indian Bank - 3.40 cr
26 Feb 2024
Charge satisfied
State Bank Of India
19 Jan 2024
Charge created
Hdfc Bank Limited - 5.23 Lakh
05 Jun 2023
Charge created
Indian Bank - 4.00 cr
16 Feb 2023
Charge created
Hdfc Bank Limited - 15.00 Lakh
10 Feb 2023
Director ceased
MONA KAUSHIK
07 Sep 2022
Charge created
Indian Bank - 5.00 cr
19 May 2022
Director appointed
VIJAYSINH VANVIRSINH CHAUHAN (Director)
Director appointed
ARVIND KHARABANDA (Director)
17 May 2022
Director ceased
ASHOK KUMAR KAPOOR
27 Apr 2022
Director ceased
DINESH CHANDRA TIWARI
10
Key Observations
Auto-generated from the data aboveRevenue grew 0.86 over the last 4 financial year(s).
Net profit margin moved from 61% to 38%.
Debt-to-equity stands at 1.42 - manageable leverage.
Net worth is positive.
7 active director(s) / partner(s); review board churn before relying on management continuity.
2 active GST registration(s) indicate ongoing business operations.
Operates a group structure with 1 subsidiary(ies) - assess on a consolidated basis.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a majority stake as per the FY 2024 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 3 security allotment(s) - amounts available in the full report.
| Company | CIN | Location |
|---|---|---|
| Herbochem Industries Private Limited | U24299UP2021PTC142599 | Barabanki, Uttar Pradesh, India |
| Zim Laboratories | L99999MH1984PLC032172 | Nagpur, Maharashtra, India |
| Velnik India | U24100RJ2017PLC058778 | Sojat, Rajasthan, India |
| Eugia Sez Private Limited | U24299TG2021PTC148856 | Hyderabad, Telangana, India |
| Fil | U24231JK1989PTC001136 | Jammu And Kashmir, Jammu & Kashmir, India |
| Kusa Chemicals | U24110MH1983PTC030449 | Mumbai, Maharashtra, India |
| Tirupati Starch & Chemicals Lt | L15321MP1985PLC003181 | Indore, Madhya Pradesh, India |
| Rusanpharma | U24230MH1994PLC077069 | Mumbai, Maharashtra, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Rajasthan Antibiotics Ltd before audits and certifications: compliance score 32/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Rajasthan Antibiotics Ltd: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Favourable lending indicators. Credit risk score 80/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Positive growth indicators. Growth score 80/100, margin trends, ownership structure and peer set for Rajasthan Antibiotics Ltd - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Review suggested. Trust score 64/100, distress signals and MSME payment-delay disclosures - know whether Rajasthan Antibiotics Ltd pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (3 case(s) on record), regulatory flags, charge documents trail and director networks for Rajasthan Antibiotics Ltd - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Rajasthan Antibiotics Ltd an active company?
Rajasthan Antibiotics Ltd has MCA status “Active” with a compliance score of 32/100 (Caution Indicated).
Is Rajasthan Antibiotics Ltd financially healthy?
Rajasthan Antibiotics Ltd has a Financial Health Score of 85/100 (Low Risk) based on its filed financial statements.
Should I do business with Rajasthan Antibiotics Ltd?
Its overall Trust Score is 64/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Rajasthan Antibiotics Ltd?
Promoters hold a majority stake - exact percentages are in the full report. 7 active director(s) are on record.
Does Rajasthan Antibiotics Ltd have loans or charges against its assets?
10 open charge(s) are registered against its assets, and 41 earlier charge(s) stand satisfied.
Is Rajasthan Antibiotics Ltd up to date with its ROC filings?
Annual filings current (balance sheet Mar 2025). Overall compliance score: 32/100 (Caution Indicated).
Is it risky to lend to Rajasthan Antibiotics Ltd?
Its Credit Risk Score is 80/100 (Low Risk). Banker verdict: Favourable lending indicators.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
